Use and Misuse of GLP-1 Receptor Agonists Among People With Eating Disorders

Дата публикации: 01-08-2026 00:00:00

This cross-sectional study evaluates the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonist use and misuse among people with eating disorders in the US.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Acute, Longer-Term, and Transdiagnostic Outcomes After Digital Interventions for Eating Disorders	0	10.8	01-07-2026
2	Time-Dependent Effects of GLP-1 Receptor Agonists on Weight Loss: A Systematic Review and Meta-Analysis of Phase 3 Trials [version 1; peer review: awaiting peer review]	0	13.63	08-08-2026
3	Smell and Taste Disturbances Among Glucagon-Like Peptide-1 Receptor Agonist Users	0	7	25-06-2026
4	Preoperative GLP-1 RA Use and Weight Loss After Bariatric Surgery	0	6.88	12-08-2026
5	Number of Americans taking GLP-1s for weight loss hits record high: Survey	0	7	07-07-2026
6	Oral GLP-1 drugs may quiet the brain’s food craving circuit	0	9.89	25-07-2026
7	Secondary Ocular Complications Associated with GLP-1 Receptor Agonist Use for Weight Loss: A Large Retrospective Cohort Study	0	5	17-07-2026
8	GLP-1 Users Are Reshaping Retail With Every Pound They Shed	0	14.13	20-07-2026
9	Emotion Dysregulation, Weight Self-Stigma, Body Dissatisfaction, and Self-Compassion in Disordered Eating Attitudes: A Serial Mediation Study Among Bangladeshi University Student	0	21.54	10-08-2026
10	Tips for providing psychological support during GLP-1 therapy	0	8.95	10-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.07. Источник: jamanetwork.com.